SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
Wendy
Lv5
1153 积分
2021-06-03 加入
最近求助
最近应助
互助留言
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
14小时前
已完结
Chromosomal aberrations +1q21 and del(17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasone
1天前
待确认
The Impact of Clone Size on the Prognostic Value of Chromosome Aberrations by Fluorescence In Situ Hybridization in Multiple Myeloma
1天前
已完结
Multiple myeloma
2天前
已完结
Anti-CD38 monoclonal antibodies in multiple myeloma with gain/amplification of chromosome arm 1q: a review of the literature
7天前
已完结
P-173 Development and validation of an individualized and weighted myeloma prognostic score system (MPSS) in patients with newly diagnosed multiple myeloma
7天前
已关闭
Recent advances in the management of multiple myeloma: clinical impact based on resource-stratification. Consensus statement of the Asian Myeloma Network at the 16th international myeloma workshop
7天前
已完结
Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma
16天前
已完结
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
28天前
已完结
A multi-center, phase Ib study of subcutaneous administration of isatuximab in combination with pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma
30天前
已完结
没有进行任何应助
感谢,点赞
14小时前
点赞
1天前
感谢,点赞
2天前
感谢
6天前
点赞,速度真快
7天前
点赞,感谢
16天前
点赞
30天前
感谢,点赞
1个月前
等太久了【积分已退回】
1个月前
感谢
1个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论